Brief: Gossamer Bio Launches Exchange Offer And Consent Solicitation Intended To Eliminate Over $120 Million Of Debt With Existing Noteholder Support
18/05/2026 12:05
May 18 (Reuters) - Gossamer Bio Inc GOSS.O: GOSSAMER BIO, INC. LAUNCHES EXCHANGE OFFER AND CONSENT SOLICITATION INTENDED TO ELIMINATE OVER $120 MILLION OF DEBT WITH EXISTING NOTEHOLDER SUPPORT GOSSAMER BIO INC - HOLDERS OF 75.2% OF EXISTING NOTES SUPPORT EXCHANGE OFFER Source text: ID:nBwc7sZmca Further company coverage: GOSS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gossamer Bio
See all newsBrief: Gossamer Bio Submits New Drug Application To US FDA For Seralutinib For The Treatment Of Pulmonary Arterial Hypertension
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing